Riskpilot← Back to searchSign inGet full accessNeuron Oy
OYDissolvedY-tunnus 1866148-0Kiannonkatu 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 2003— employeeswww.livesaatio.fi
Revenue 2024
EUR 0
EBITDA margin
—
-74% vs 2023
Equity ratio
75.5%
Financial strength
Net profit 2024
EUR -943
-83% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -1K | -74% |
| Net profit | EUR -943 | -83% |
| Total assets | EUR 9K | +1% |
| Equity | EUR 6K | -13% |
| Employees | — | — |
Legal name
Neuron Oy
Y-tunnus number
1866148-0
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
26. marraskuuta 2003
Share capital
EUR 8 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Yhtiön toimiala on harjoittaa neurologisten ja geriatristen potilaiden tutkimukseen, hoitoon ja kuntoutukseen liittyvää tutkimus-, kehittämis-, konsultointi- ja koulutustoimintaa. Toimialaan kuuluu myös toiminnan tuloksena kehitettyjen lääketieteellisten laitteiden ja menetelmien tuotteistaminen, markkinointi ja myynti.
Address
Kiannonkatu 2
Phone
+3580401360828
Email
info@inlive.fi
Website
www.livesaatio.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −0 | −0 |
| EBITDA | −0 | −0 | −0 | −1 | −1 | −1 |
| Depreciation & amort. | — | — | — | — | −0 | −0 |
| EBIT | −0 | −0 | −0 | −1 | −1 | −1 |
| Net financials | — | — | — | — | 0 | 0 |
| Profit before tax | −0 | −0 | −0 | −1 | −1 | −1 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −0 | −0 | −0 | −1 | −1 | −1 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 9 | 9 | 8 | 8 | 8 | 9 |
| Equity | 9 | 9 | 8 | 8 | 7 | 6 |
| Long-term debt | — | — | — | 0 | 1 | 2 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | 0 | 1 | 2 |
EBITDA margin
-112600.0%
This company
15.8%
Market median
-712758% vs market
20192024
Equity ratio
75.5%
This company
38.2%
Market median
+98% vs market
20192024
Return on equity
-14.6%
This company
18.4%
Market median
-179% vs market
20192024
Net profit margin
-94300.0%
This company
8.1%
Market median
-1164298% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TP Audit | Audit | 2019 | — | — |
HJ Deputy auditor | Deputy auditor | 2013 | — | — |
LH Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
AP Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
JT Deputy Member | Deputy Member | 2021 | — | — |
SH Audit | Audit | 2013 | — | — |
SS | Audit | 2021 | — | — |
RM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
KM Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairperson | 2021 | — | — | |
| Chairperson | 2013 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Neuron Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Pekka Loikkanen | Audit | 0 companies |
| Heikki Juhani Nuutinen | Deputy auditor | 0 companies |
| Laura Henriette Airaksinen | Chief Executive Officer | 0 companies |
| Auvo Pauli Kalevi Vilpponen | Chief Executive Officer | 0 companies |
| Juha Tatu Henrik Holopainen | Deputy Member | 0 companies |
| Sirpa Helena Koponen | Audit | 0 companies |
| Sami Seppo Sakari Posti | Audit | 0 companies |
| Riikka Marika Pikkarainen | Chief Executive Officer | 0 companies |
| Kirsi Marja Aromäki | Audit | 0 companies |
| Anna-Maria Tuokko | Board of Directors | 0 companies |
| Mervi Helena Huttunen | Board of Directors | 0 companies |
| Mervi Johanna Huttula | Board of Directors | 0 companies |
| Miika Eskonpoika Keijonen | Board of Directors | 0 companies |
| Tiina Arja Maaria Pitkänen | Board of Directors | 0 companies |
| Marja Orvokki Pajulahti | Board of Directors | 0 companies |
| Markku Juhani Hämäläinen | Board of Directors | 0 companies |
| Jussi Antero Somervuo | Board of Directors | 0 companies |
| Joonas Tapio Sakki | Board of Directors | 0 companies |
| Juha Matias Keski-Filppula | Chairperson | 0 companies |
| Kauko Kalervo Pitkänen | Chairperson | 0 companies |